Development and validation of a hypoxia-immune-based microenvironment gene signature for predicting survival in non-small cell lung cancer
The hypoxia-immune microenvironment signature serves as a robust prognostic classifier for NSCLC, providing a quantitative framework for personalized risk stratification and clinical decision support.
Authors
- Qiubo Huang
- Ping Zhao (ORCID: https://orcid.org/0000-0001-5168-0307)
- Yunchao Huang (ORCID: https://orcid.org/0000-0002-9840-8199)
- Xiangwu Zhang (ORCID: https://orcid.org/0000-0002-6236-6281)
- Lianhua Ye (ORCID: https://orcid.org/0000-0002-4048-7437)
- Guangqiang Zhao
- Wanling Chen (ORCID: https://orcid.org/0000-0002-3001-7730)
- Rong Zhou (ORCID: https://orcid.org/0009-0009-3038-1514)
Institutions
- Kunming Medical University (CN)
- Yunnan Institute of Environmental Sciences (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1007/s12672-025-03319-z
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- National Natural Science Foundation of China